PennyStockPayCheck.com Rss

Featured Posts

Chase Bank Limits Cash Withdrawals, Bans International... Before you read this report, remember to sign up to http://pennystockpaycheck.com for 100% free stock alerts Chase Bank has moved to limit cash withdrawals while banning business customers from sending...

Read more

Richemont chairman Johann Rupert to take 'grey gap... Billionaire 62-year-old to take 12 months off from Cartier and Montblanc luxury goods groupRichemont's chairman and founder Johann Rupert is to take a year off from September, leaving management of the...

Read more

Cambodia: aftermath of fatal shoe factory collapse... Workers clear rubble following the collapse of a shoe factory in Kampong Speu, Cambodia, on Thursday

Read more

Spate of recent shock departures by 50-something CEOs While the rising financial rewards of running a modern multinational have been well publicised, executive recruiters say the pressures of the job have also been ratcheted upOn approaching his 60th birthday...

Read more

UK Uncut loses legal challenge over Goldman Sachs tax... While judge agreed the deal was 'not a glorious episode in the history of the Revenue', he ruled it was not unlawfulCampaign group UK Uncut Legal Action has lost its high court challenge over the legality...

Read more

Solar3D Files Patent Application in China for Breakthrough 3-Dimensional Solar Cell

Category : World News

Company Intellectual Property for Its Ultra-Efficient Silicon Solar Cell Will Be Protected in One of the World’s Largest Solar Markets

Read more from the original source: Solar3D Files Patent Application in China for Breakthrough 3-Dimensional Solar Cell

Post to Twitter

Viratech Corp. (VIRA: OTC Pink Current) | Vireatch Announces Agreement For Exclusive License For Wellness Formula That Supports Weight And Metabolism Control

Category : Stocks

VIRATECH ANNOUNCES AGREEMENT FOR EXCLUSIVE LICENSE FOR WELLNESS FORMULA THAT SUPPORTS WEIGHT AND METABOLISM CONTROL

STOCKTON, CALIFORNIA/March

Post to Twitter

Viratech Corp. (VIRA: OTC Pink Current) | Viratech Announces An Agreement For An Exclusive Marketing License For Device For Better Blood Testing

Category : World News

VIRATECH ANNOUNCES AN AGREEMENT FOR AN EXCLUSIVE MARKETING LICENSE FOR DEVICE FOR BETTER BLOOD TESTING

STOCKTON, CALIFORNIA/March 165, /Date, 20132 / Newswire/ — Viratech, Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for an exclusive license from Health Care Intellectual Properties, LLC, to Viratech for United States Provisional Patent Application 61677474, titled “Device to Prevent Hemolysis.”

This patent-pending technology is a new medical device that may assist in obtaining more accurate blood test results, and was created to address the need to prevent problems associated with Point of Care or finder-stick blood tests. The technology can be used when only small amounts of blood are needed for testing. The device described in this patent is a blood drawing kit that may prevent the rupture of red cells in the sample which can invalidate certain test results.

Post to Twitter

Viratech Corp. (VIRA: OTC Link) | Viratech Announces Agreement For Exclusive Marketing License For Method To Treat Breast Disease

Category : Stocks

VIRATECH ANNOUNCES AGREEMENT FOR EXCLUSIVE MARKETING LICENSE FOR METHOD TO TREAT BREAST DISEASE

STOCKTON, CALIFORNIA/March 8 , 2013 / Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for an exclusive license from Health Care Intellectual Properties, LLC to Viratech, Corp, for United States Provisional Patent Application 61696297, titled “Method of Treating Breast Disease.”

Breast cancer is a common cancer in women. Early diagnosis and treatments are vital for better outcomes. This formula consists of an anti-disease, anti-cancer formula with a technology designed for the treatment breast disease, including cancer.

Post to Twitter

Viratech Corp. (VIRA: OTC Link) | Viratech Announces Agreement For Exclusive Marketing License For Method To Treat Breast Disease

Category : Stocks, World News

VIRATECH ANNOUNCES AGREEMENT FOR EXCLUSIVE MARKETING LICENSE FOR METHOD TO TREAT BREAST DISEASE

STOCKTON, CALIFORNIA/March 8 , 2013 / Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for an exclusive license from Health Care Intellectual Properties, LLC to Viratech, Corp, for United States Provisional Patent Application 61696297, titled “Method of Treating Breast Disease.”

Breast cancer is a common cancer in women. Early diagnosis and treatments are vital for better outcomes. This formula consists of an anti-disease, anti-cancer formula with a technology designed for the treatment breast disease, including cancer.

Post to Twitter

Viratech Corp. (VIRA: OTC Link) | Viratech Announces Agreement For Exclusive Marketing License For Method To Treat Breast Disease

Category : World News

VIRATECH ANNOUNCES AGREEMENT FOR EXCLUSIVE MARKETING LICENSE FOR METHOD TO TREAT BREAST DISEASE

STOCKTON, CALIFORNIA/March 8 , 2013 / Newswire/ — Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, announced today the signing of an agreement for an exclusive license from Health Care Intellectual Properties, LLC to Viratech, Corp, for United States Provisional Patent Application 61696297, titled “Method of Treating Breast Disease.”

Breast cancer is a common cancer in women. Early diagnosis and treatments are vital for better outcomes. This formula consists of an anti-disease, anti-cancer formula with a technology designed for the treatment breast disease, including cancer.

Post to Twitter

Viratech Corp. (VIRA: OTC Link) | Rachel Boulds Named CFO of Cancer.im

Category : Stocks

RACHEL BOULDS IS NAMED CHIEF FINANCIAL OFFICER OF CANCER.IM

STOCKTON, CALIFORNIA/December 24, 2012 / Newswire/ — Viratech Corp. (OTC: VIRA),

Post to Twitter

Viratech Corp. (VIRA: OTC Link) | John Stein, MD Joins Viratech Advisory Board

Category : Stocks

JOHN
STEIN MD JOINS VIRATECH ADVISORY BOARD

STOCKTON, CALIFORNIA/ November 9, 2012 /Globe Newswire/ — Viratech, Corp.
(OTC: VIRA), the first open source biotech research social network platform,
announced today
the addition of John Stein MD to its Advisory Committee as Head of the Clinical
Research Committee for the Company.

Post to Twitter

US trade judge sides with Apple

Category : Business, World News

A US International Trade Commission judge, in a preliminary ruling, says Samsung infringed four of Apple’s intellectual property patents.

Go here to see the original: US trade judge sides with Apple

Post to Twitter

Tech firms meet at patent pow-wow

Category : Business

Apple. Google, Microsoft, Nokia, Samsung and others tech firms meet with regulators and patent officials to discuss changes to intellectual property laws.

Read the original here: Tech firms meet at patent pow-wow

Post to Twitter